China's Harbour BioMed to focus on another patent case after US$20 million damages award (opens original article in a new tab)

China's Harbour BioMed won a patent case against Amgen and will focus on another case with higher financial stakes.

• Harbour BioMed won a patent case against Amgen
• Harbour BioMed will focus on another patent case with greater financial implications
• The company received a US$20 million damages award